Relying on cutting-edge technologies such as DNA Encoded Libraries (DEL) screening, we have developed unique advantages in high-throughput drug screening. Through our high-throughput screening platform system, we have independently developed target activity evaluation methods and trial protocol with DEL screening, and have demonstrated the reliability of combining AI technology with DEL screening for drug discovery strategies.

Our high-throughput drug screening platform offers comprehensive screening outcomes and data analysis capabilities, thereby significantly boosting the efficiency of drug research and development for pharmaceutical enterprises and academic research institutions alike.